Abbreviated New Drug Applications and following the path to generic drug approval. Generic drug applications are termed “abbreviated” because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness. Instead, generic applicants
Similar Posts
The Center for Research on Complex Generics
FDA awards a 5-year grant to the University of Maryland and the University of Michigan to establish a Center for Research on Complex Generics (CRCG).Applicator Recall: Integra LifeSciences Removes Extended Tip Applicator Due to Potential Sterility and Endotoxin Concerns
Extended Tip Applicator recall due to potential non-sterile product and high endotoxin levels. May cause inflammation or infection if used.BsUFA IV: Fiscal Years 2028-2032
On September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.Expanded Access to Investigational Drugs for Treatment Use – Questions and Answers – 04/15/2026
An informative webinar on the FDA guidance Expanded Access to Investigational Drugs for Treatment Use: Questions and AnswersLupin Limited – 09/16/2025
Lupin Limited – 09/16/2025. Country: India. Record Type: 483Contra Reumas may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Contra Reumas, a product promoted and sold for joint pain on various websites, including naturistarex.com, and possibly in some retail stores.